News

The $350 million NERB boosts the university’s ability to engage in multi-site clinical trials, targeting treatments for both rare and common diseases.
Jim FessendenUMass Chan Medical SchoolNew research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome ...
Patrick Gallagher has been named deputy executive vice chancellor of people strategy at Worcester, Mass.-based UMass Chan Medical School, effective June 30. Prior to his new role, Mr. Gallagher served ...
Critically ill children and their families are given life-changing wishes by Make-A-Wish. Disney is Make-A-Wish's largest ...
More than 5 years after the pandemic's start, COVID remains a public health challenge. From October 2024 to April 2025, the CDC estimated 28,000 to 46,000 deaths and 230,000 to 390,000 ...
Lawyers, students, researchers and higher education leaders debate whether Harvard should consider a deal with the Trump ...
SAN ANTONIO, June 26, 2025--bioAffinity scientists present breakthrough research on using siRNAs to knock down two receptors ...
People living with Sickle Cell Disease (SCD) in Nigeria have lamented that the high cost of medication and poor access to comprehensive care are weighing heavily on them and their families.They also ...
New research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...
New research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...